IL6 and lung carcinoma: The inflammatory microenvironment also promotes the progression and metastasis of lung cancer, and TNF-α CRP and IL-6 are common inflammatory factors, and their serum levels are generally elevated in lung cancer patients and are significantly correlated with tumor activity.